Cardiac Resynchronization Therapy News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

ECHO-CRT: Resynchronization no help, may be harmful in narrow-QRS heart failure
QRS width, certainly not echocardiographic dyssynchrony, remains the most effective measure for selecting patients for cardiac resynchronization therapy. (Source: theHeart.org)
Source: theHeart.org - September 3, 2013 Category: Cardiology Source Type: news

Real-World Use Confirms Bigger CRT Benefits for Some Patients (CME/CE)
(MedPage Today) -- Among Medicare beneficiaries with heart failure, cardiac resynchronization therapy had the greatest impact in those with left bundle-branch block and a longer QRS duration, consistent with clinical trial data, a study showed. (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - August 13, 2013 Category: Consumer Health News Source Type: news

Real-World Use Confirms Bigger CRT Benefits for Some (CME/CE)
(MedPage Today) -- Among Medicare beneficiaries with heart failure, cardiac resynchronization therapy had the greatest impact in those with left bundle-branch block and a longer QRS duration, consistent with clinical trial data, a study showed. (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - August 13, 2013 Category: Consumer Health News Source Type: news

Study identifies characteristics of heart failure patients more likely to benefit from implantation of cardiac resynchronization device
In a large population of Medicare beneficiaries with heart failure who underwent implantation of a cardiac resynchronization therapy defibrillator, patients who had the cardiac characteristics of left bundle-branch block and longer QRS duration had the lowest risks of death and all-cause, cardiovascular, and heart failure readmission, according to a study in the August 14 issue of JAMA... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 13, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

First ESC Cardiac Pacing And Resynchronization Guidelines Ever To Incorporate A New Section Called 'Clinical Perspectives'
The 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy developed in collaboration with the European Heart Rhythm Association (EHRA), have created a new classification system for bradyarrhythmias according to mechanisms rather than aetiology. The guidelines, presented at the EHRA EUROPACE meeting in Athens, Greece, and published simultaneously in the European Heart Journal and Europace, have been redesigned to offer a more accessible format for users... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 27, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Practical approach makes new ESC cardiac pacing and resynchronization guidelines accessible to all
(European Society of Cardiology) The 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy have created a new classification system for bradyarrhythmias according to mechanisms rather than aetiology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2013 Category: Global & Universal Source Type: news

MULIN study challenges widely held assumption that sickest benefit most in CRT
Long term clinical outcome of cardiac resynchronisation therapy (CRT) according to baseline QRS duration: Cardiac mortality is highest in CRT patients with QRS durations greater than 200 ms, finds the international MULIN study. MULIN represents the largest study yet to address the relationship between pre-implant QRS duration and long-term outcome for patients undergoing CRT. Read more Topics: Arrhythmias (Source: ESC News and Press)
Source: ESC News and Press - June 18, 2013 Category: Cardiology Source Type: news

St. Jude Medical Announces FDA Approval Of High-Voltage Devices With New Safety Features
St. Jude Medical, Inc., a global medical device company, recently announced U.S. Food and Drug Administration (FDA) approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) (Source: Medical Design Online News)
Source: Medical Design Online News - June 11, 2013 Category: Medical Equipment Source Type: news

Devices in Heart Failure
Survival for heart failure patients has improved substantially over the last decades. This is a result of improved pharmacologic treatment, multidisciplinary management strategies and recent advances in device therapy, such as implantable cardiac defibrillators (ICD) and cardiac resynchronization therapy (CRT). Read more Topics: Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 25, 2013 Category: Cardiology Source Type: news

St. Jude Medical Announces CE Mark And Launch Of First Quadripolar CRT Pacemaker
Allure Quadra elevates the standard for Cardiac Resynchronization Therapy Pacemakers St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval and European launch of its Allure Quadra™ Cardiac Resynchronization Therapy Pacemaker (CRT-P). This CRT-P system offers more pacing options to deliver higher success rates, as evidenced by robust clinical data. Allure Quadra CRT-P brings the quadripolar lead technology to the pacemaker market for the first time... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 2, 2013 Category: Consumer Health News Tags: Medical Devices / Diagnostics Source Type: news

St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
Allure Quadra elevates the standard for Cardiac Resynchronization Therapy Pacemakers ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical device company, today announced CE Mark approval and European l... Devices, Cardiology, Regulatory, Product LaunchSt. Jude Medical, Allure Quadra, CRT-P, quadripolar, pacemaker (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 30, 2013 Category: Pharmaceuticals Source Type: news

St. Jude Medical Announces CE Mark And Launch Of First Quadripolar CRT Pacemaker
Allure Quadra elevates the standard for Cardiac Resynchronization Therapy Pacemakers St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval and European launch of its Allure Quadra™ Cardiac Resynchronization Therapy Pacemaker (CRT-P). The first-to-market quadripolar CRT-P system allows for increased implant efficiencies that result in fewer surgical revisions, and offers more pacing options to deliver higher success rates, as evidenced by robust clinical data... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 30, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Conflicting Results From Two Trials Of Cardiac Resynchronization Therapy
Two new trials have ended up reporting conflicting results regarding the expansion of the indication for cardiac resynchronization therapy (CRT) for patients without a wide QRS interval. The positive results of the smaller trial seem likely to be undermined by the early stopping of the much larger trial. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 25, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

Weight Loss In Patients With Implanted Defibrillators Predicts Worse Health Outcomes
Even minor weight loss is associated with worse health outcomes among patients implanted with a certain type of defibrillator known as cardiac resynchronization therapy with defibrillator (CRT-D), according to research presented at the American College of Cardiology's 62nd Annual Scientific Session. People with symptoms of heart failure who have an implantable CRT-D device may believe that losing weight will ultimately improve their long-term health outcomes... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 11, 2013 Category: Consumer Health News Tags: Heart Disease Source Type: news

Appropriate Use Criteria For ICDs And CRT
The American College of Cardiology and the Heart Rhythm Society, along with key specialty societies, have released appropriate use criteria for implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT). The document provides assessed levels of appropriateness for implanting the devices in 369 real-life clinical scenarios, with the goal of enhancing physician and patient decision making and improving care and health outcomes... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 4, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news